- €97.14bn
- €108.84bn
- €46.72bn
- 62
- 71
- 46
- 66
Annual balance sheet for Sanofi SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11,152 | 13,400 | 8,980 | 7,927 | 7,657 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9,787 | 10,746 | 11,040 | 10,629 | 397 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 30,564 | 34,026 | 30,670 | 42,588 | 30,953 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11,976 | 11,684 | 11,814 | 11,601 | 11,511 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 120,242 | 126,722 | 126,464 | 132,798 | 126,806 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 21,295 | 23,964 | 24,207 | 29,162 | 28,346 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 51,561 | 51,938 | 52,424 | 55,291 | 55,430 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 68,681 | 74,784 | 74,040 | 77,507 | 71,376 |
| Total Liabilities & Shareholders' Equity | 120,242 | 126,722 | 126,464 | 132,798 | 126,806 |
| Total Common Shares Outstanding |